Eye on Innovation
clinical trials
- How Digital Biomarkers Enable Patient-Centric Clinical Trials
- Affect-Laden Risk Profiles Derived from Two Days of EMA Predict Substance Use and Quality of Life Three- And Six-Months After SUD Treatment.
- Implementation of Smartphone Systems to Improve Quality of Life for People with Substance Use Disorder: Interim Report on a Randomized Controlled Trial
- Enabling Clinical Trial Innovation Through AI Regulation at FDA
- A Randomized Controlled Study of Remote Computerized Cognitive, Neurofeedback, and Combined Training in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder
- A Randomized, Clinical Trial Investigating the use of a Digital Intervention to Reduce Delirium-Associated Agitation
- Digital Health Technologies for Remote Data Acquisition in Clinical Investigations
- Clinical Trial to Assess Efficacy of Virtual Alcohol Use Disorder Treatment
- Patient Engagement: The True Benchmark in Clinical Trials